中东和非洲注射笔市场预测至 2028 年 - COVID-19 影响和区域分析(按类型(一次性注射笔和可重复使用注射笔)、治疗(糖尿病、生长激素治疗、自身免疫性疾病、生育力、癌症和其他治疗)、和最终用户(医院和诊所、家庭护理等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 136    |    Report Code: BMIRE00028193    |    Category: Life Sciences

Middle East & Africa Injection Pen Market

中东和中东地区非洲注射笔市场预计将从2022年的201610万美元增长到2028年的287294万美元。预计2022年至2028年复合年增长率为6.1%。

 

中东和非洲地区生物制品专利到期和生物仿制药的使用增加非洲注射笔市场

 

生物制剂被广泛开发用于治疗癌症、多发性硬化症、和糖尿病。这些药物各具特色,制造商拥有 20 年制造和分销此类药物的专利。由于大多数专利已经过期或即将过期,其他市场参与者已经开始推出自己的此类药物版本,即生物仿制药。生物仿制药(价格低廉、受到政府和保险公司青睐的仿制药)在过去几年中比原研生物制剂获得了巨大的吸引力。制药市场参与者正在推动生物仿制药的采用,这进一步创造了对其注射笔的需求。根据AJMC的数据,截至2022年12月,美国共有40种生物仿制药获得批准,并有25种新的生物仿制药在美国上市。此外,由于反应迅速,注射剂已被大规模使用,从而产生了注射剂的需求笔以确保安全。此外,注射笔制造商不断提供正确使用注射笔的培训,以避免相关危险,例如针刺伤和高血糖,这进一步有望为注射笔市场创造机会。因此,生物仿制药的使用增加、专利到期以及注射剂的使用增加可能会在未来几年为注射笔市场的增长创造充足的机会。

 

中东和中东地区非洲注射笔市场概况

 

中东和非洲非洲注射笔市场分为南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区。非洲。该地区的市场增长归因于糖尿病和不孕症发病率的增加以及公司对产品开发的不断努力。沙特阿拉伯的糖尿病发病率正在迅速增加,并且由于肥胖和超重公民的比例很高,预计未来几年将持续居高不下。据世界卫生组织(WHO)称,由于不健康的生活方式和体力活动不足,沙特阿拉伯儿童更容易在很小的时候就患上糖尿病,并且该国青少年糖尿病的患病率持续上升最近几年。根据IDF的报告,沙特阿拉伯有10%的人患有糖尿病,到2045年,患病率将几乎翻倍。此外,约427万沙特阿拉伯人患有糖尿病,还有186万人尚未被诊断出患有这种疾病。预计到 2030 年和 2045 年,这一数字将分别达到 560 万和 750 万。

 

中东和中东地区到2028年非洲注射笔市场收入及预测(百万美元)

           

                     

 

中东和中东地区非洲注射笔市场细分

 

中东和非洲非洲注射笔市场根据类型、疗法、最终用户和国家进行细分。根据类型,注射笔市场分为一次性注射笔和可重复使用注射笔。一次性注射笔细分市场到 2022 年将占据更大的市场份额。

 

基于治疗,中东和非洲地区非洲注射笔市场分为糖尿病治疗、生长激素治疗、自身免疫性疾病治疗、生育治疗、癌症治疗等。糖尿病治疗领域在 2022 年占据最大的市场份额。

 

基于最终用户、中东和非洲地区。非洲注射笔市场分为医院和医疗机构。诊所、家庭护理等。家庭护理细分市场在 2022 年占据最大的市场份额。

 

按国家/地区、中东和非洲地区划分。非洲注射笔市场分为沙特阿拉伯、南非、阿联酋以及中东和非洲其他地区。非洲。中东其他地区和2022 年,非洲在市场上占据主导地位。

 

阿斯利康公司 (AstraZeneca Plc)、碧迪金森公司 (Becton Dickinson and Co)、礼来公司 (Eli Lilly)、Gerresheimer AG、Haselmeier GmbH、 Merck KGaA、Novo Nordisk AS、Owen Mumford Ltd、Sanofi SA 和 Teva Pharmaceutical Industries Ltd 都是在中东和中东地区运营的领先公司。非洲注射笔市场。



Middle East & Africa Injection Pen Strategic Insights

Strategic insights for Middle East & Africa Injection Pen involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-injection-pen-market-strategic-framework.webp
Get more information on this report

Middle East & Africa Injection Pen Report Scope

Report Attribute Details
Market size in 2022 US$ 2,016.10 Million
Market Size by 2028 US$ 2,872.94 Million
Global CAGR (2022 - 2028) 6.1%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 类型
  • 一次性注射笔
  • 可重复使用注射笔
By 治疗
  • 糖尿病
  • 生长激素治疗
  • 自身免疫性疾病
  • 生育
  • 癌症
  • 其他治疗
By 最终用户
  • 医院和诊所
  • 家庭护理
Regions and Countries Covered 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • AstraZeneca Plc
  • Becton Dickinson and Co
  • Eli Lilly and Co
  • Gerresheimer AG
  • Haselmeier GmbH
  • Merck KGaA
  • Novo Nordisk AS
  • Owen Mumford Ltd
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd
  • Get more information on this report

    Middle East & Africa Injection Pen Regional Insights

    The regional scope of Middle East & Africa Injection Pen refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/middle-east-and-africa-injection-pen-market-geography.webp
    Get more information on this report

    The List of Companies - Middle East & Africa Injection Pen Market

    1. AstraZeneca Plc
    2. Becton Dickinson and Co
    3. Eli Lilly and Co
    4. Gerresheimer AG
    5. Haselmeier GmbH
    6. Merck KGaA
    7. Novo Nordisk AS
    8. Owen Mumford Ltd
    9. Sanofi SA
    10. Teva Pharmaceutical Industries Ltd
    Frequently Asked Questions
    How big is the Middle East & Africa Injection Pen Market?

    The Middle East & Africa Injection Pen Market is valued at US$ 2,016.10 Million in 2022, it is projected to reach US$ 2,872.94 Million by 2028.

    What is the CAGR for Middle East & Africa Injection Pen Market by (2022 - 2028)?

    As per our report Middle East & Africa Injection Pen Market, the market size is valued at US$ 2,016.10 Million in 2022, projecting it to reach US$ 2,872.94 Million by 2028. This translates to a CAGR of approximately 6.1% during the forecast period.

    What segments are covered in this report?

    The Middle East & Africa Injection Pen Market report typically cover these key segments-

  • 类型 (一次性注射笔, 可重复使用注射笔)
  • 治疗 (糖尿病, 生长激素治疗, 自身免疫性疾病, 生育, 癌症, 其他治疗)
  • 最终用户 (医院和诊所, 家庭护理)
  • What is the historic period, base year, and forecast period taken for Middle East & Africa Injection Pen Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Injection Pen Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in Middle East & Africa Injection Pen Market?

    The Middle East & Africa Injection Pen Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • AstraZeneca Plc
  • Becton Dickinson and Co
  • Eli Lilly and Co
  • Gerresheimer AG
  • Haselmeier GmbH
  • Merck KGaA
  • Novo Nordisk AS
  • Owen Mumford Ltd
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd
  • Who should buy this report?

    The Middle East & Africa Injection Pen Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa Injection Pen Market value chain can benefit from the information contained in a comprehensive market report.